Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Total glucosides of paeony in early rheumatoid arthritis
ChiCTR-TRC-12002656Phase 4Completed
- Sponsor
- Peking University People's Hospital
- Start
- Dec 2012
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of total glucosides of paeony in rheumatoid arthritis (RA) (2 arms), sponsored by Peking University People's Hospital. Primary endpoints: DAS28 and ACR20/50/70. Started Dec 2012; status: completed.
02
Drugs
total glucosides of paeony
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR-TRC-12002656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002656.